Director/PDMR Shareholding

RNS Number : 5287P

GlaxoSmithKline PLC

08 February 2019

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr N Hirons
b)	Position/status	SVP, Global Ethics & Compliance
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	American Depositary Shares ('ADSs') ISIN: US37733W1053
b)	Nature of the transaction	The exercise of options over 4,600 ADSs, granted on 17 February 2009 under the GlaxoSmithKline Share Option Plan.
c)	Price(s) and volume(s)	Price(s) Volume(s) $33.4200 1,608 (Non-Qualified Stock Option) $33.4200 2,992 (Incentive Stock Option)
d)	Aggregated information Aggregated volume Price	4,600 $33.4200
e)	Date of the transaction	2019-02-07
f)	Place of the transaction	n/a

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr N Hirons
b)	Position/status	SVP, Global Ethics & Compliance
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	American Depositary Shares ('ADSs') ISIN: US37733W1053
b)	Nature of the transaction	The sale of 4,600 ADSs, following the exercise of options granted on 17 February 2009 under the GlaxoSmithKline Share Option Plan.
c)	Price(s) and volume(s)	Price(s) Volume(s) $41.0800 1,608 (Non-Qualified Stock Option) $41.0800 2,992 (Incentive Stock Option)
d)	Aggregated information Aggregated volume Price	4,600 $41.0800
e)	Date of the transaction	2019-02-07
f)	Place of the transaction	New York Stock Exchange (XNYS)

 

END

 

 

DSHLVLFBKLFFBBL